{
    "nctId": "NCT06131632",
    "briefTitle": "Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant Chemotherapy",
    "officialTitle": "Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant Chemotherapy in Patients With Clinical Complete Response (ConSIBreC): a Randomized Clinical Trial",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Inflammatory Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "local recurrence rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with inflammatory breast cancer\n* Clinical complete response after neoadjuvant chemiotherapy\n* Targeted tumor\n* Written informed consent\n\nExclusion Criteria:\n\n* Metastasis\n* Progression disease\n* Recurrent disease\n* Contraindications to adjuvant radiation therapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}